Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 26% ± 12% | |
GABAergic neuron | 3 studies | 26% ± 5% | |
glutamatergic neuron | 3 studies | 35% ± 2% | |
oligodendrocyte | 3 studies | 16% ± 0% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 25% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1372.84 | 1445 / 1445 | 100% | 23.71 | 183 / 183 |
intestine | 100% | 1618.71 | 966 / 966 | 100% | 17.50 | 527 / 527 |
lung | 100% | 1763.78 | 578 / 578 | 100% | 16.96 | 1155 / 1155 |
ovary | 100% | 1076.16 | 180 / 180 | 100% | 13.27 | 430 / 430 |
breast | 100% | 1461.22 | 459 / 459 | 100% | 23.01 | 1116 / 1118 |
brain | 100% | 1007.24 | 2629 / 2642 | 100% | 19.00 | 705 / 705 |
thymus | 100% | 1408.25 | 653 / 653 | 99% | 16.56 | 601 / 605 |
stomach | 100% | 1162.09 | 359 / 359 | 99% | 18.93 | 284 / 286 |
bladder | 100% | 1340.00 | 21 / 21 | 99% | 13.61 | 500 / 504 |
prostate | 100% | 1242.31 | 244 / 245 | 100% | 17.03 | 500 / 502 |
uterus | 100% | 1354.26 | 170 / 170 | 99% | 13.63 | 455 / 459 |
kidney | 100% | 1210.42 | 89 / 89 | 98% | 14.44 | 879 / 901 |
pancreas | 99% | 801.45 | 325 / 328 | 98% | 13.28 | 175 / 178 |
adrenal gland | 100% | 1387.03 | 258 / 258 | 97% | 11.57 | 223 / 230 |
liver | 100% | 1462.52 | 226 / 226 | 95% | 9.08 | 387 / 406 |
skin | 100% | 1778.21 | 1808 / 1809 | 94% | 13.88 | 444 / 472 |
adipose | 100% | 1615.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.01 | 29 / 29 |
muscle | 100% | 5690.09 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1289.25 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.67 | 1 / 1 |
blood vessel | 100% | 1412.80 | 1334 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 14.23 | 44 / 45 |
peripheral blood | 97% | 1452.14 | 901 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 1144.64 | 819 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 74% | 5.98 | 59 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0016579 | Biological process | protein deubiquitination |
GO_0032435 | Biological process | negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0140311 | Molecular function | protein sequestering activity |
GO_0005515 | Molecular function | protein binding |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
Gene name | USP38 |
Protein name | Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (HP43.8KD) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38) Ubiquitin specific peptidase 38 |
Synonyms | KIAA1891 |
Description | FUNCTION: Deubiquitinating enzyme that plays a role in various cellular processes, including DNA repair, cell cycle regulation, and immune response . Plays a role in the inhibition of type I interferon signaling by mediating the 'Lys-33' to 'Lys-48' ubiquitination transition of TBK1 leading to its degradation . Cleaves the ubiquitin chain from the histone demethylase LSD1/KDM1A and prevents it from degradation by the 26S proteasome, thus maintaining LSD1 protein level in cells . Plays a role in the DNA damage response by regulating the deacetylase activity of HDAC1 . Mechanistically, removes the 'Lys-63'-linked ubiquitin chain promoting the deacetylase activity of HDAC1 in response to DNA damage . Acts also as a specific deubiquitinase of histone deacetylase 3/HDAC3 and cleaves its 'Lys-63'-linked ubiquitin chains to lower its histone deacetylase activity . Regulates MYC levels and cell proliferation via antagonizing ubiquitin E3 ligase FBXW7 thereby preventing MYC 'Lys-48'-linked ubiquitination and degradation . Participates in antiviral response by removing both 'Lys-48'-linked and 'Lys-63'-linked polyubiquitination of Zika virus envelope protein E . Constitutively associated with IL-33R/IL1RL1, deconjugates its 'Lys-27'-linked polyubiquitination resulting in its autophagic degradation . . |
Accessions | A0A804HIS3 A0A804HIT0 ENST00000683224.1 ENST00000307017.9 [Q8NB14-1] ENST00000682469.1 A0A804HL80 Q8NB14 ENST00000511739.1 ENST00000510377.5 [Q8NB14-2] ENST00000684586.1 H0Y9H5 |